These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15464343)

  • 21. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 22. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
    Taniguchi T; Kawasaki T; Miyai N; Kamitani T; Kawasaki S; Sugihara H
    J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction.
    Blangy H; Sadoul N; Dousset B; Radauceanu A; Fay R; Aliot E; Zannad F
    Europace; 2007 Sep; 9(9):724-9. PubMed ID: 17526509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The application of biochemical indexes detecting in sudden cardiac death in forensic autopsy].
    Mao RM; Zheng QQ; Li XL; Xiong CY; Zhu BL
    Fa Yi Xue Za Zhi; 2009 Dec; 25(6):451-4. PubMed ID: 20225625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting sudden death in the general population: another step, N terminal B-type natriuretic factor levels.
    Chugh SS; Reinier K
    Circulation; 2009 Jun; 119(22):2863-4. PubMed ID: 19506123
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sudden death: from epidemiology to therapeutic management-prevention].
    Aliot E
    Arch Mal Coeur Vaiss; 2000 Jun; Spec No():27-9. PubMed ID: 10949712
    [No Abstract]   [Full Text] [Related]  

  • 27. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
    Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical issues with implantable defibrillators.
    Veenhuyzen GD; Simpson CS
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):173-4; author reply 174. PubMed ID: 15679652
    [No Abstract]   [Full Text] [Related]  

  • 30. Ethical issues with implantable defibrillators.
    Brennan FJ
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):897-8. PubMed ID: 15271005
    [No Abstract]   [Full Text] [Related]  

  • 31. Implanted cardioverter defibrillators for the prevention of sudden death.
    Dorian P; Talajic M; Tang A
    Can J Cardiol; 2005 May; 21 Suppl A():31A-36A. PubMed ID: 15953942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Heart rate turbulence--a new predictor of sudden cardiac death].
    Jurek S; Sredniawa B; Musialik-Łydka A; Kalarus Z
    Pol Merkur Lekarski; 2007 Jul; 23(133):55-9. PubMed ID: 18051831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
    O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
    Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction.
    Khan SQ; Quinn P; Davies JE; Ng LL
    Heart; 2008 Jan; 94(1):40-3. PubMed ID: 17488769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers in clinical practice.
    Alpert JS
    Am J Med; 2011 Aug; 124(8):677-8. PubMed ID: 21683327
    [No Abstract]   [Full Text] [Related]  

  • 36. [Heart failure with or without myocardial infarct. Which patient profits from defibrillator?].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219115
    [No Abstract]   [Full Text] [Related]  

  • 37. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
    Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain.
    Kwan G; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL
    J Am Coll Cardiol; 2007 Mar; 49(11):1186-92. PubMed ID: 17367663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comments on ethical issues with implantable defibrillators by F. James Brennan.
    Rahmoeller G
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):899. PubMed ID: 15271006
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.